Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs

Charles D. Swerdlow, Michael Shehata, Peng-Sheng Chen

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The upper limit of vulnerability (ULV) is the weakest shock strength at or above which ventricular fibrillation (VF) is not induced when the shock is delivered during the vulnerable period. The ULV, a measurement made in regular rhythm, provides an estimate of the minimum shock strength required for reliable defibrillation that is as accurate or more accurate than the defibrillation threshold (DFT). The ULV hypothesis of defibrillation postulates a mechanistic relationship between the ULV - measured during regular rhythm - and the minimum shock strength that defibrillates reliably. Vulnerability testing can be applied at implantable cardioverter defibrillator (ICD) implant to confirm a clinically adequate defibrillation safety margin without inducing VF in 75%-95% of ICD recipients. Alternatively, the ULV provides an accurate patient-specific safety margin with a single fibrillation-defibrillation episode. Programming first ICD shocks based on patient-specific measurements of ULV rather than programming routinely to maximum output shortens charge time and may reduce the probability of syncope as ICDs age and charge times increase. Because the ULV is more reproducible than the DFT, it provides greater statistical power for clinical research with fewer episodes of VF. Limited evidence suggests that vulnerability testing is safer than conventional defibrillation testing.

Original languageEnglish (US)
Pages (from-to)258-270
Number of pages13
JournalPACE - Pacing and Clinical Electrophysiology
Volume30
Issue number2
DOIs
StatePublished - Feb 2007
Externally publishedYes

Fingerprint

Shock
Implantable Defibrillators
Ventricular Fibrillation
Syncope
Patient Safety
Safety
Research

Keywords

  • Defibrillation
  • Defibrillation testing
  • Defibrillation threshold
  • Implantable cardioverter defibrillator
  • T-wave shock
  • Upper limit of vulnerability

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs. / Swerdlow, Charles D.; Shehata, Michael; Chen, Peng-Sheng.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 30, No. 2, 02.2007, p. 258-270.

Research output: Contribution to journalArticle

@article{7bf1c9efcd174038924fae450385a1e1,
title = "Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs",
abstract = "The upper limit of vulnerability (ULV) is the weakest shock strength at or above which ventricular fibrillation (VF) is not induced when the shock is delivered during the vulnerable period. The ULV, a measurement made in regular rhythm, provides an estimate of the minimum shock strength required for reliable defibrillation that is as accurate or more accurate than the defibrillation threshold (DFT). The ULV hypothesis of defibrillation postulates a mechanistic relationship between the ULV - measured during regular rhythm - and the minimum shock strength that defibrillates reliably. Vulnerability testing can be applied at implantable cardioverter defibrillator (ICD) implant to confirm a clinically adequate defibrillation safety margin without inducing VF in 75{\%}-95{\%} of ICD recipients. Alternatively, the ULV provides an accurate patient-specific safety margin with a single fibrillation-defibrillation episode. Programming first ICD shocks based on patient-specific measurements of ULV rather than programming routinely to maximum output shortens charge time and may reduce the probability of syncope as ICDs age and charge times increase. Because the ULV is more reproducible than the DFT, it provides greater statistical power for clinical research with fewer episodes of VF. Limited evidence suggests that vulnerability testing is safer than conventional defibrillation testing.",
keywords = "Defibrillation, Defibrillation testing, Defibrillation threshold, Implantable cardioverter defibrillator, T-wave shock, Upper limit of vulnerability",
author = "Swerdlow, {Charles D.} and Michael Shehata and Peng-Sheng Chen",
year = "2007",
month = "2",
doi = "10.1111/j.1540-8159.2007.00659.x",
language = "English (US)",
volume = "30",
pages = "258--270",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs

AU - Swerdlow, Charles D.

AU - Shehata, Michael

AU - Chen, Peng-Sheng

PY - 2007/2

Y1 - 2007/2

N2 - The upper limit of vulnerability (ULV) is the weakest shock strength at or above which ventricular fibrillation (VF) is not induced when the shock is delivered during the vulnerable period. The ULV, a measurement made in regular rhythm, provides an estimate of the minimum shock strength required for reliable defibrillation that is as accurate or more accurate than the defibrillation threshold (DFT). The ULV hypothesis of defibrillation postulates a mechanistic relationship between the ULV - measured during regular rhythm - and the minimum shock strength that defibrillates reliably. Vulnerability testing can be applied at implantable cardioverter defibrillator (ICD) implant to confirm a clinically adequate defibrillation safety margin without inducing VF in 75%-95% of ICD recipients. Alternatively, the ULV provides an accurate patient-specific safety margin with a single fibrillation-defibrillation episode. Programming first ICD shocks based on patient-specific measurements of ULV rather than programming routinely to maximum output shortens charge time and may reduce the probability of syncope as ICDs age and charge times increase. Because the ULV is more reproducible than the DFT, it provides greater statistical power for clinical research with fewer episodes of VF. Limited evidence suggests that vulnerability testing is safer than conventional defibrillation testing.

AB - The upper limit of vulnerability (ULV) is the weakest shock strength at or above which ventricular fibrillation (VF) is not induced when the shock is delivered during the vulnerable period. The ULV, a measurement made in regular rhythm, provides an estimate of the minimum shock strength required for reliable defibrillation that is as accurate or more accurate than the defibrillation threshold (DFT). The ULV hypothesis of defibrillation postulates a mechanistic relationship between the ULV - measured during regular rhythm - and the minimum shock strength that defibrillates reliably. Vulnerability testing can be applied at implantable cardioverter defibrillator (ICD) implant to confirm a clinically adequate defibrillation safety margin without inducing VF in 75%-95% of ICD recipients. Alternatively, the ULV provides an accurate patient-specific safety margin with a single fibrillation-defibrillation episode. Programming first ICD shocks based on patient-specific measurements of ULV rather than programming routinely to maximum output shortens charge time and may reduce the probability of syncope as ICDs age and charge times increase. Because the ULV is more reproducible than the DFT, it provides greater statistical power for clinical research with fewer episodes of VF. Limited evidence suggests that vulnerability testing is safer than conventional defibrillation testing.

KW - Defibrillation

KW - Defibrillation testing

KW - Defibrillation threshold

KW - Implantable cardioverter defibrillator

KW - T-wave shock

KW - Upper limit of vulnerability

UR - http://www.scopus.com/inward/record.url?scp=33847372957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847372957&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8159.2007.00659.x

DO - 10.1111/j.1540-8159.2007.00659.x

M3 - Article

C2 - 17338725

AN - SCOPUS:33847372957

VL - 30

SP - 258

EP - 270

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 2

ER -